Vetoquinol Canada launches a product for veterinary dermatology
by CM Staff
PHOVIA® is a system from Vetoquinol that seeks to alleviate the limitations of the current standard of care through the use of Fluorescent Light Energy (FLE).
The PHOVIA® System is for topical application and is intended to create an environment supporting the skin’s own regeneration mechanisms in a physical way. (CNW Group/Vétoquinol N.-A. Inc.)
LAVALTRIE — Vetoquinol Canada announces that veterinarians across the country now have a new tool available to try and address many of today’s challenges in the field of pet dermatology.
PHOVIA® is a system from Vetoquinol that seeks to alleviate the limitations of the current standard of care through the use of Fluorescent Light Energy (FLE). Although this technology is already used in human medicine, Vetoquinol is the pioneer of its use in the veterinary world.
Launched in Europe and the United States in 2021, it is now available in Canada. In the field of companion animal dermatology, which is experiencing several challenges, Vetoquinol and its many partners are can now use this new technology. Responsible use of antibiotics, reduced quality of life of affected animals and their owners due to the intensity and chronic nature of dermatological cases and the time required to treat and resolve skin problems are only a few examples of challenges PHOVIA® seek to help to overcome.
The company says that studies in dogs have shown that the use of polychromatic Fluorescent Light Energy supported acceleration of natural skin regeneration in situations where the skin was damaged. Several sustained efforts both in Canada and internationally are being made to demonstrate the benefits of this technology.
